Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Luminex Molecular Diagnostics, a division of Luminex has signed a global sales and distribution agreement with Abbott's molecular diagnostics business.
Subscribe to our email newsletter
Under the terms of the agreement, Abbott will have exclusive rights to distribute Luminex’s new xTAG Respiratory Viral Panel (RVP) worldwide outside the US and semi-exclusive rights in the US.
Douglas Bryant, executive vice president and COO of Luminex, said: “We believe that xTAG RVP has the potential to significantly impact the detection, treatment, and control of respiratory viruses worldwide. Abbott’s long-standing dedication to improve the quality of human health, combined with their global customer base, will make them a strong partner in bringing xTAG RVP to more physicians, public health authorities and patients around the world.”